CHINA PHARMA HOLDINGS INC (CPHI) Stock Balance Sheet
NYSEARCA:CPHI - American Stock Exchange - US16941T3023 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 718.69K | 1.42M | 2.03M | 4.86M | 958.00K | |||
| Receivables | 407.23K | 730.00K | 909.00K | 836.00K | 586.00K | |||
| Inventories | 2.50M | 3.73M | 2.95M | 3.34M | 3.71M | |||
| Other Current Assets | 114.20K | 110.00K | 78.00K | 59.00K | 74.00K | |||
| Total Current Assets | 3.74M | 6.00M | 5.96M | 9.09M | 5.32M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.36M | 7.22M | 10.01M | 13.41M | 15.61M | |||
| Intangibles | 4.36M | 3.25M | 1.81M | 148.00K | 182.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 9.73M | 10.47M | 11.82M | 13.56M | 15.80M | |||
| TOTAL ASSETS | 13.47M | 16.47M | 17.78M | 22.65M | 21.12M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 2.52M | 1.97M | 6.24M | 4.33M | 2.04M | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 2.30M | |||
| Accrued Expenses | 142.85K | 377.00K | 445.00K | 384.00K | 229.00K | |||
| Accounts Payable | 390.24K | 966.00K | 667.00K | 927.00K | 1.24M | |||
| Other Current Liabilities | 1.70M | 3.51M | 5.39M | 4.87M | 5.60M | |||
| Total Current Liabilities | 4.76M | 6.82M | 12.74M | 10.51M | 11.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.43M | 1.41M | 0.00 | 5.25M | 904.00K | |||
| Deferred Taxes/Income | 750.09K | 742.00K | 755.00K | 824.00K | 806.00K | |||
| Other Non-Current Liabilities | 0.00 | 40.00K | 0.00 | 44.00K | 0.00 | |||
| Total Non-Current Liabilities | 2.18M | 2.19M | 755.00K | 6.12M | 1.71M | |||
| TOTAL LIABILITIES | 6.94M | 9.02M | 13.49M | 16.63M | 13.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -42.80M | -39.29M | -36.21M | -32.24M | -28.84M | |||
| Additional Paid In Capital | 37.79M | 35.28M | 28.85M | 25.64M | 24.45M | |||
| Common Shares | 17.86K | 11.00K | 75.00K | 47.00K | 46.00K | |||
| Other Shareholders' Equity | 11.52M | 11.45M | 11.57M | 12.56M | 12.35M | |||
| Shares Outstanding | 17.86M | 10.63M | 1.50M | 947.00K | 912.00K | |||
| Tangible Book Value per Share | 0.12 | 0.40 | 1.66 | 6.20 | 8.58 | |||
| Total Shareholders' Equity | 6.53M | 7.46M | 4.29M | 6.02M | 8.01M | |||
| TOTAL LIABILITIES AND EQUITY | 13.47M | 16.47M | 17.78M | 22.65M | 21.12M | |||
| Statistics | ||||||||
| Debt/Equity | 0.61 | 0.45 | N/A | 1.59 | 0.37 | |||
| Current Ratio | 0.79 | 0.88 | 0.47 | 0.86 | 0.47 | |||
| Return On Assets (ROA) | -35.23% | -18.70% | -22.34% | -15.01% | -13.58% | |||
| Return On Equity (ROE) | -72.67% | -41.30% | -92.61% | -56.48% | -35.82% | |||
All data in USD , ROIC based on taxRate of 0.21